In the fragmented and complex US healthcare system, the market value of pharmacy benefit managers (PBM) has reached new heights.
PBMs help administer drug insurance benefits in a variety of ways, including by negotiating prices with manufacturers and pharmacies, establishing formularies and processing claims.
Looking into the sector and its development, USA-based analyst Research and Markets says the market for PBMs is now worth around $491 billion.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze